Saved in:
Bibliographic Details
Main Authors: Chipman, Jonathan J., Sverdlov, Oleksandr, Uschner, Diane
Format: Preprint
Published: 2025
Subjects:
Online Access:https://arxiv.org/abs/2510.07153
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866909831486504960
author Chipman, Jonathan J.
Sverdlov, Oleksandr
Uschner, Diane
author_facet Chipman, Jonathan J.
Sverdlov, Oleksandr
Uschner, Diane
contents Participants in clinical trials are often viewed as a unique, finite population. Yet, statistical analyses often assume that participants were randomly sampled from a larger population. Under Complete Randomization, Randomization-Based Inference (RBI; a finite population inference) and Analysis of Variance (ANOVA; a random sampling inference) provide asymptotically equivalent difference-in-means tests. However, sequentially-enrolling trials typically employ restricted randomization schemes, such as block or Maximum Tolerable Imbalance (MTI) designs, to reduce the chance of chronological treatment imbalances. The impact of these restrictions on RBI and ANOVA concordance is not well understood. With real-world frames of reference, such as rare and ultra-rare diseases, we review full versus random sampling of finite populations and empirically evaluate finite population Type I error when using ANOVA following randomization restrictions. Randomization restrictions strongly impacted ANOVA Type I error, even for trials with 1,000 participants. Properly adjusting for restrictions corrected Type I error. We corrected for block randomization, yet leave open how to correct for MTI designs. More directly, RBI accounts for randomization restrictions while ensuring correct finite population Type I error. Novel contributions are: 1) deepening the understanding and correction of RBI and ANOVA concordance under block and MTI restrictions and 2) using finite populations to estimate the convergence of Type I error to a nominal rate. We discuss the challenge of specifying an estimand's population and reconciling with sampled trial participants.
format Preprint
id arxiv_https___arxiv_org_abs_2510_07153
institution arXiv
publishDate 2025
record_format arxiv
spellingShingle Randomization Restrictions: Their Impact on Type I Error When Experimenting with Finite Populations
Chipman, Jonathan J.
Sverdlov, Oleksandr
Uschner, Diane
Methodology
Participants in clinical trials are often viewed as a unique, finite population. Yet, statistical analyses often assume that participants were randomly sampled from a larger population. Under Complete Randomization, Randomization-Based Inference (RBI; a finite population inference) and Analysis of Variance (ANOVA; a random sampling inference) provide asymptotically equivalent difference-in-means tests. However, sequentially-enrolling trials typically employ restricted randomization schemes, such as block or Maximum Tolerable Imbalance (MTI) designs, to reduce the chance of chronological treatment imbalances. The impact of these restrictions on RBI and ANOVA concordance is not well understood. With real-world frames of reference, such as rare and ultra-rare diseases, we review full versus random sampling of finite populations and empirically evaluate finite population Type I error when using ANOVA following randomization restrictions. Randomization restrictions strongly impacted ANOVA Type I error, even for trials with 1,000 participants. Properly adjusting for restrictions corrected Type I error. We corrected for block randomization, yet leave open how to correct for MTI designs. More directly, RBI accounts for randomization restrictions while ensuring correct finite population Type I error. Novel contributions are: 1) deepening the understanding and correction of RBI and ANOVA concordance under block and MTI restrictions and 2) using finite populations to estimate the convergence of Type I error to a nominal rate. We discuss the challenge of specifying an estimand's population and reconciling with sampled trial participants.
title Randomization Restrictions: Their Impact on Type I Error When Experimenting with Finite Populations
topic Methodology
url https://arxiv.org/abs/2510.07153